Please use this identifier to cite or link to this item:
Scopus Web of ScienceĀ® Altmetric
Type: Journal article
Title: Metastatic colorectal cancer treatment and survival: the experience of major public hospitals in South Australia over three decades
Author: Roder, D.
Karapetis, C.
Wattchow, D.
Moore, J.
Singhal, N.
Joshi, R.
Keefe, D.
Fusco, K.
Buranyi-Trevarton, D.
Sharplin, G.
Price, T.
Citation: Asian Pacific Journal of Cancer Prevention, 2015; 16(14):5923-5931
Publisher: Korean Institute of Science and Technology Information
Issue Date: 2015
ISSN: 1513-7368
Statement of
David Roder, Christos S Karapetis, David Wattchow, James Moore, Nimit Singhal, Rohit Joshi, Dorothy Keefe, Kellie Fusco, Dianne Buranyi-Trevarton, Greg Sharplin, Timothy J Price
Abstract: Background: Registry data from four major public hospitals indicate trends over three decades from 1980 to 2010 in treatment and survival from colorectal cancer with distant metastases at diagnosis (TNM stage IV). Materials and Methods: Kaplan-Meier product-limit estimates and Cox proportional hazards models for investigating disease-specific survival and multiple logistic regression analyses for indicating first-round treatment trends. Results: Two-year survivals increased from 10% for 1980-84 to 35% for 2005-10 diagnoses. Corresponding increases in five-year survivals were from 3% to 16%. Time-to-event risk of colorectal cancer death approximately halved (hazards ratio: 0.48 (0.40, 0.59) after adjusting for demographic factors, tumour differentiation, and primary sub-site. Survivals were not found to differ by place of residence, suggesting reasonable equity in service provision. About 74% of cases were treated surgically and this proportion increased over time. Proportions having systemic therapy and/or radiotherapy increased from 12% in 1980-84 to 61% for 2005-10. Radiotherapy was more common for rectal than colonic cases (39% vs 7% in 2005-10). Of the cases diagnosed in 2005-10 when less than 70 years of age, the percentage having radiotherapy and/or systemic therapy was 79% for colorectal, 74% for colon and 86% for rectum (&RS)) cancers. Corresponding proportions having: systemic therapies were 75%, 71% and 81% respectively; radiotherapy were 24%, 10% and 46% respectively; and surgery were 75%, 78% and 71% respectively. Based on survey data on uptake of offered therapies, it is likely that of these younger cases, 85% would have been offered systemic treatment and among rectum (&RS) cases, about 63% would have been offered radiotherapy. Conclusions: Pronounced increases in survivals from metastatic colorectal cancer have occurred, in keeping with improved systemic therapies and surgical interventions. Use of radiotherapy and/or systemic therapy has increased markedly and patterns of change accord with clinical guideline recommendations.
Keywords: Colorectal cancer;metastatic;clinical care;survival trends;
Rights: Copyright status unknown
RMID: 0030037562
DOI: 10.7314/APJCP.2015.16.14.5923
Appears in Collections:Medicine publications

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.